Your browser doesn't support javascript.
loading
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Jelinek, Tomas; Sevcikova, Tereza; Zihala, David; Popkova, Tereza; Kapustova, Veronika; Broskevicova, Lucie; Capkova, Lenka; Rihova, Lucie; Bezdekova, Renata; Sevcikova, Sabina; Zidlik, Vladimir; Havel, Martin; Plonkova, Hana; Jungova, Alexandra; Minarik, Jiri; Stork, Martin; Pour, Ludek; Pavlicek, Petr; Spicka, Ivan; Maisnar, Vladimir; Radocha, Jakub; Simicek, Michal; Hajek, Roman.
Afiliação
  • Jelinek T; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. tomas.jelinek.md@gmail.com.
  • Sevcikova T; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Zihala D; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Popkova T; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Kapustova V; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Broskevicova L; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
  • Capkova L; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Rihova L; Institute of Biostatistics and Analyses, Ltd, Brno, Czech Republic.
  • Bezdekova R; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Sevcikova S; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
  • Zidlik V; Babak Myeloma Group, Department of Pathofysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Havel M; Department of Pathology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Plonkova H; Department of Nuclear Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
  • Jungova A; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Minarik J; Hematology and Oncology Department, Charles University Hospital Pilsen, Czechia, Czech Republic.
  • Stork M; Department of Hematooncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czechia, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Czechia, Czech Republic.
  • Pavlicek P; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Czechia, Czech Republic.
  • Spicka I; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Maisnar V; 1st Medical Department-Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.
  • Radocha J; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Simicek M; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Leukemia ; 36(1): 288-291, 2022 01.
Article em En | MEDLINE | ID: mdl-34247197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmócitos / Células Clonais / Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmócitos / Células Clonais / Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article